News Archive

• September, 2015 -

  Come visit the Nortis booth at 2015 4th TERMIS World Congress on September 8th – 11th in Boston, MA, and learn more about our commercial product. 

• June, 2015 -

  Come visit the Nortis booth at the Life Science Innovation Northwest on June 30 – July 1st in Seattle, WA, and listen to a presentation by our CEO, Thomas Neumann, to learn more about our company and upcoming commercial product.

• June, 2015 -

  Come visit the Nortis booth at the World Pharma Congress on June 10 – 12th in Boston, MA, and learn more about our upcoming commercial product.

• June, 2015 -

  Read about how the University of Pittsburgh and the University of Washington are developing organs-on-a-chip using the Nortis technology in Discover magazine’s latest edition.

• May, 2015 -

  Nortis headquarters has officially moved to a new location in Eastlake! Our manufacturing facility is located across the lake in Woodinville, WA.

• March, 2015 -

  Read about Nortis in this exciting NewsBeat article- UW receives $6 million for Predictive Toxicology Center

• December, 2014 -

  From all of us here at Nortis- Happy Holidays! 2015 promises to be an exciting year! 

• November, 2014 -

  Learn more about Nortis at our Functional Analysis & Screening Technologies Congress exhibit. November 17-19 in Boston, MA.

• October, 2014 -

  Visit the Nortis exhibit at Vascular Biology 2014, taking place on the beautiful Asilomar Conference Grounds in Monterey, CA. 

• August, 2014 -

  See how Nortis technology is being utilized to create a “kidney on a chip” in the Pacific Science Center’s new exhibit “Building A New You: Harnessing The Power Of Stem Cells”. Watch the Video.

• July, 2014 -

  Nortis publishes article entitled  Tissue-engineered microenvironment systems for modeling human vasculature in Experimental Biology and Medicine, DOI: 10.1177/1535370214539228 [Epub ahead of print].

• July, 2014 -

  MedCity News publishes article on upcoming commercial launch. Read the Article.

• June, 2014 -

  Nortis receives multimillion dollar Series A funding to support commercial launch.

• June, 2014 -

  Nortis introduces its technology at Life Science Innovation Northwest.

• January, 2014 -

  Nortis is awarded pilot study funding from the PATH Malaria Vaccine Initiative (MVI).

• September, 2013 -

  Nortis is awarded NIH/NCI, SBIR contract for developing a brain metastasis assay for drug screening.

• September, 2013 -

  Nortis is recognized by the NHLBI to be among the top six most promising biotech companies in 2013. Read More.

• August, 2013 -

  Nortis is awarded funding by the PATH Malaria Vaccine Initiative (MVI) to develop a platform for testing transmission blocking vaccines.

• April, 2012 -

  Nortis is selected by the NCI SBIR investor forum as one of the top 18 most promising biotech companies in 2012 (http://sbir.cancer.gov/investorforum/cfa.asp).

• November, 2012 -

  Nortis is awarded a grant from the Bill & Melinda Gates Foundation to develop a chip for testing anti-malaria drugs.

• October, 2012 -

  UW TV features Nortis on its October UW 360 segment. “How can a credit-card sized chip help accelerate the development of safe and effect drug therapies?”  (http://uwtv.org/watch/ZYs_yfeQiiA/)

• July, 2012 -

  UW/Nortis, Inc among the 17 recipients of $132M tissue chip project awards.

• July, 2012 -

  Nortis in the Seattle Times: UW works to simulate kidney, in hopes of improving drug trials (http://seattletimes.com/html/health/2018763092_tissuechip25m.html).

• April, 2012 -

  National Cancer Institute chooses Nortis as one of the eighteen “strongest and most promising NCI SBIR companies”.

• April, 2012 -

  Nortis moved its labs and offices into the University of Washington C4C New Ventures Facility (NVF). The NVF is a business incubator that provides select start-ups access to critical facilities and promotes commercialization.

• January, 2012 -

  Nortis officially spins off from VisionGate.